Elizabeth Taber is a pharmacist who is specialized in Psychiatric in Butner, North Carolina. Patients can reach her at 300 Veazey Dr, Butner or contact her on 919-764-2000. Active license number of Elizabeth Taber is 27430 for Psychiatric in North Carolina. Elizabeth Taber is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Elizabeth Taber speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Elizabeth Taber
Specialization:
Psychiatric
Credentials:
PHARMD
Gender:
Female
Location:
300 Veazey Dr, Butner, North Carolina, 27509-1668
Phone:
919-764-2000
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Elizabeth Taber are as mentioned below.
NPI Number:
1538714217
NPI Enumeration Date:
08 Aug, 2019
NPI Last Update On:
08 Aug, 2019
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elizabeth Taber are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
27430
North Carolina
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3323 Rolling Hill Rd, Durham, North Carolina
Zip:
27705-5543
Phone Number:
--
Fax Number:
--
Patients can reach Elizabeth Taber at 300 Veazey Dr, Butner, North Carolina or can call on phone at 919-764-2000.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.